There are at least 55 lawsuits against Novo Nordisk for their diabetes drug, Ozempic that has been frequently prescribed off-label as a “miracle” weight loss drug. A multi-district legislation has moved all federal Ozempic lawsuits into the Eastern district of Pennsylvania under Judge Gene Pratter. The current lawsuits have claims of gastrointestinal issues, the most severe of which is gastoperesis, also known as stomach paralysis. Intestinal blockage is another common gastrointestinal issue that has been linked to the drug. Novo Nordisk attempted to have some of these cases dismissed on the basis that these side effects are well documented within the approval by the FDA.

The pharmaceutical manufacturer attempted to gain immunity from  lawsuits  since the FDA approved-label acknowledges the side effect. Daily Mail report referred to a woman who will experience life-long diarrhea as a result of side effects from using Ozempic. Another woman said she nearly lost her job for being so sick she could not go to work for the day. When she did attempt to go to work, she would soil her clothes. She would bring a change of clothing every day she went to work.

Daily Mail spoke with attorney Cameron Stephenson, who has approximately 100 clients with gastroparesis from taking Ozempic. Stephenson and his law office are investigating 1,000 more cases. Right now, the lawsuits are only focusing on gastrointestinal issues, although anecdotal reports of suicidal ideation have been reported.

The Food and Drug Administration’s Adverse Event Reporting System (FAERS) had 262 reports regarding suicidal ideation or depression. Among those claims are 20 reports of suicide. The FDA has been investigating the link between suicidal ideation and semaglutide drugs, including Ozempic and Wegovy. They have not found a causal association between semaglutide drugs and depression.

The Wegovy drug insert says to warn patients about potential worsening of suicidal ideation, depression, or changes in mood. Meanwhile, a new NIH study was released that indicates semaglutide decreases suicidal ideation. Novo Nordisk also claims that there was no suicidal ideation witnessed in the clinical trials for Ozempic.

The FDA recently approved Wegovy to reduce risk of serious heart problems. The FDA label for Wegovy states heart rate increases are positively associated with use of the drug. In the animal study for Wegovy, the FDA approval states the following: “In the offspring, reduced growth and fetuses with visceral (heart blood vessels) and skeletal (cranial bones, vertebra, ribs) abnormalities were observed at the human exposure.”

The HighWire has reported on suicidal ideation from Ozempic, lawsuits, and European health agency investigations. Jeffrey Jaxen also reported on the Highwire regarding suicidal ideation and stomach paralysis.

The lawsuits against Novo Nordisk are moving forward while more alleged victims are piling up in the queue. Ozempic is under FDA investigation for hair loss and suicidal ideation over a year after investigating the drug for intestinal blockages. The initial reports indicate the FDA doesn’t see a safety issue with the drug despite hundreds of FAERS (FDA Adverse Event Reporting System) submissions linking the drug to suicidal thoughts.

Ozempic does not list a warning of suicidal thoughts. Novo Nordisk’s other semaglutide drug for weight loss, Wegovy, does say to tell your medical provider if you have or have had depression, suicidal thoughts, or mental health issues.

Steven Middendorp

Steven Middendorp is an investigative journalist, musician, and teacher. He has been a freelance writer and journalist for over 20 years. More recently, he has focused on issues dealing with corruption and negligence in the judicial system. He is a homesteading hobby farmer who encourages people to grow their own food, eat locally, and care for the land that provides sustenance to the community.

Other Headlines

Coronavirus

ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

The Informed Consent Action Network (ICAN) and REACT 19 held a joint press conference today to reveal a trove of secret recordings and FOIA documents of Peter Marks, the former Director of the Center for Biologics Evaluation and Research. The press conference included ICAN Founder Del Bigtree, Attorney Aaron Siri, and REACT 19’s Brianne Dressen.Continue reading ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

More news about Coronavirus

Health & Nutrition

HHS Releases 400-page Gender Affirming Care Report Citing Weak Evidence For Medical Interventions in Minors

The Department of Health and Human Services (HHS) has released a 400-page umbrella review of systematic reviews of treatments for pediatric gender dysphoria in children and adolescents. The report cites 409 sources and concludes that there is weak evidence to support medical interventions for minors and there are significant risks. The report suggests more researchContinue reading HHS Releases 400-page Gender Affirming Care Report Citing Weak Evidence For Medical Interventions in Minors

More news about Health & Nutrition

Vaccines

ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

The Informed Consent Action Network (ICAN) and REACT 19 held a joint press conference today to reveal a trove of secret recordings and FOIA documents of Peter Marks, the former Director of the Center for Biologics Evaluation and Research. The press conference included ICAN Founder Del Bigtree, Attorney Aaron Siri, and REACT 19’s Brianne Dressen.Continue reading ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

More news about Vaccines

Science & Tech

23andMe Files for Chapter 11 Bankruptcy; Genetic Data of 15 Million Users at Risk of Sale

The genetic data of 15 million people will soon be for sale as 23andMe has filed for Chapter 11 bankruptcy. The attorneys general for California and New York issued consumer alerts to advise consumers to take action to protect their data. New York AG Rob Bonta said “There’s health insurance companies that are interested inContinue reading 23andMe Files for Chapter 11 Bankruptcy; Genetic Data of 15 Million Users at Risk of Sale

More news about Science & Tech

Environment

New Study Links GM Crops to Higher Pesticide Use, Defying Industry Claims

A new study published in the Journal of Agrarian Change finds that genetically modified (GM or GMO) seeds have led to substantial increases in the amount of pesticides used on agricultural crops. This directly contradicts the claims made by agrochemical companies like Bayer, who have funded studies showing that GM crops decrease pesticide and herbicideContinue reading New Study Links GM Crops to Higher Pesticide Use, Defying Industry Claims

More news about Environment

Policy

ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

The Informed Consent Action Network (ICAN) and REACT 19 held a joint press conference today to reveal a trove of secret recordings and FOIA documents of Peter Marks, the former Director of the Center for Biologics Evaluation and Research. The press conference included ICAN Founder Del Bigtree, Attorney Aaron Siri, and REACT 19’s Brianne Dressen.Continue reading ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

More news about Policy